Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. 2003

Hiroshi Imamura, and Yutaka Matsuyama, and Eiji Tanaka, and Takao Ohkubo, and Kiyoshi Hasegawa, and Shinichi Miyagawa, and Yasuhiko Sugawara, and Masami Minagawa, and Tadatoshi Takayama, and Seiji Kawasaki, and Masatoshi Makuuchi
Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. himamura-tky@umin.ac.jp

OBJECTIVE We conducted a retrospective cohort study to investigate factors to early and late phase recurrence of hepatocellular carcinoma (HCC). METHODS The study population consisted of 249 patients including 157 with cirrhosis who underwent hepatectomy for HCC. The endpoint was time-to-recurrence. Using a Cox regression model, factors to early and late phase recurrences were investigated censoring recurrence-free patients at the 2-year time point and in patients without recurrence at 2 years. RESULTS Actuarial probability of overall recurrence at 1, 3, and 5 years were 0.301, 0.623, and 0.790, respectively, with a median follow-up of 624 days. Early recurrence was observed in 123 out of 249 patients; while late recurrence was found in 61 out of 113 patients. Factors to early recurrence were as follows: non-anatomical resection, presence of microscopic vascular invasion, and serum alpha-fetoprotein level >or=32 ng/ml. Those contributing to late phase recurrence were higher grade of hepatitis activity, multiple tumors, and gross tumor classification. CONCLUSIONS Variables associated with metastatic recurrence were factors to early phase recurrence; whereas those related with elevated carcinogenesis contributed to late phase recurrence, thus providing an epidemiological evidence that different mechanisms, i.e. metastasis and de novo, are involved in intrahepatic recurrence after hepatectomy for HCC.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D005260 Female Females
D006498 Hepatectomy Excision of all or part of the liver. (Dorland, 28th ed) Hepatectomies
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Hiroshi Imamura, and Yutaka Matsuyama, and Eiji Tanaka, and Takao Ohkubo, and Kiyoshi Hasegawa, and Shinichi Miyagawa, and Yasuhiko Sugawara, and Masami Minagawa, and Tadatoshi Takayama, and Seiji Kawasaki, and Masatoshi Makuuchi
July 2007, American journal of surgery,
Hiroshi Imamura, and Yutaka Matsuyama, and Eiji Tanaka, and Takao Ohkubo, and Kiyoshi Hasegawa, and Shinichi Miyagawa, and Yasuhiko Sugawara, and Masami Minagawa, and Tadatoshi Takayama, and Seiji Kawasaki, and Masatoshi Makuuchi
October 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Hiroshi Imamura, and Yutaka Matsuyama, and Eiji Tanaka, and Takao Ohkubo, and Kiyoshi Hasegawa, and Shinichi Miyagawa, and Yasuhiko Sugawara, and Masami Minagawa, and Tadatoshi Takayama, and Seiji Kawasaki, and Masatoshi Makuuchi
June 2014, Annals of surgical treatment and research,
Hiroshi Imamura, and Yutaka Matsuyama, and Eiji Tanaka, and Takao Ohkubo, and Kiyoshi Hasegawa, and Shinichi Miyagawa, and Yasuhiko Sugawara, and Masami Minagawa, and Tadatoshi Takayama, and Seiji Kawasaki, and Masatoshi Makuuchi
August 2000, Cancer,
Hiroshi Imamura, and Yutaka Matsuyama, and Eiji Tanaka, and Takao Ohkubo, and Kiyoshi Hasegawa, and Shinichi Miyagawa, and Yasuhiko Sugawara, and Masami Minagawa, and Tadatoshi Takayama, and Seiji Kawasaki, and Masatoshi Makuuchi
February 1992, Cancer,
Hiroshi Imamura, and Yutaka Matsuyama, and Eiji Tanaka, and Takao Ohkubo, and Kiyoshi Hasegawa, and Shinichi Miyagawa, and Yasuhiko Sugawara, and Masami Minagawa, and Tadatoshi Takayama, and Seiji Kawasaki, and Masatoshi Makuuchi
May 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association,
Hiroshi Imamura, and Yutaka Matsuyama, and Eiji Tanaka, and Takao Ohkubo, and Kiyoshi Hasegawa, and Shinichi Miyagawa, and Yasuhiko Sugawara, and Masami Minagawa, and Tadatoshi Takayama, and Seiji Kawasaki, and Masatoshi Makuuchi
March 2016, Surgical oncology,
Hiroshi Imamura, and Yutaka Matsuyama, and Eiji Tanaka, and Takao Ohkubo, and Kiyoshi Hasegawa, and Shinichi Miyagawa, and Yasuhiko Sugawara, and Masami Minagawa, and Tadatoshi Takayama, and Seiji Kawasaki, and Masatoshi Makuuchi
July 2021, Annals of gastroenterological surgery,
Hiroshi Imamura, and Yutaka Matsuyama, and Eiji Tanaka, and Takao Ohkubo, and Kiyoshi Hasegawa, and Shinichi Miyagawa, and Yasuhiko Sugawara, and Masami Minagawa, and Tadatoshi Takayama, and Seiji Kawasaki, and Masatoshi Makuuchi
May 2006, AJR. American journal of roentgenology,
Hiroshi Imamura, and Yutaka Matsuyama, and Eiji Tanaka, and Takao Ohkubo, and Kiyoshi Hasegawa, and Shinichi Miyagawa, and Yasuhiko Sugawara, and Masami Minagawa, and Tadatoshi Takayama, and Seiji Kawasaki, and Masatoshi Makuuchi
January 2002, The British journal of surgery,
Copied contents to your clipboard!